Craig Heneghan on the importance of reshoring America’s drug manufacturing

Craig Heneghan, Senior Advisor and Board Member of Argentum Pharmaceuticals, explains just how important it is for the United States to reshore generic drug manufacturing: “If we were sourcing a drug outside the U.S., that was a single source pharmaceutical. And that country, for whatever reason, halted the shipment of that product…. In 8 to 16 weeks we would be out of stock of that product.”